What is the Alpa Laboratories Ltd share price today?

The share price of NSE:ALPA-EQ on 07 Sep 2026 (as of 10:58:46 IST) is ₹62.99.

What is the NSE:ALPA-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:ALPA-EQ 52 week high low range shows a high of ₹97.90 and a low of ₹46.10.

What is the Alpa Laboratories Ltd market cap?

As on 07 Sep 2026, Alpa Laboratories Ltd market cap is ₹133.57 Cr.

What is the shareholding pattern of Alpa Laboratories Ltd Stock?

The shareholding pattern of Alpa Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 57.19% Foreign Institutional Investors (FII): 0.35% Domestic Institutional Investors (DII): 0.07% Mutual Funds: 0% Retail & Others: 42.39% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Alpa Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Alpa Laboratories Ltd is 30.51, and the Price-to-Book (PB) ratio is 1.28, as on 07 Sep 2026.

Alpa Laboratories Share Price

59.07+0.00 (-2.19%)

-36.61% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.19%

1 Week

-0.47%

1 Month

-3.87%

3 Month

-13.77%

6 Month

+14.41%

YTD

-23.97%

1 Year

-36.61%

5 Year

+14.70%

10 Year

+65.46%

Max

-3.16%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

58.61

58.35

55.76

46.10

High

61.60

62.35

65.30

78.89

94.00

About

Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber about 15 kilometers from the city of Indore in Central India. The company has been manufacturing Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

ALPANSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

59-0.35 (-0.59%)

58.35

62.35

129Cr

Alpa Laboratories Share Price

59.07+0.00 (-2.19%)

-36.61% past 1 Year

Financial overview

Compounded Sales Growth

10 years7%

5 years6%

3 years0%

Last year3%

Compounded Profit Growth

10 years-

5 years60%

3 years11%

Last year16%

Stock Price CAGR

10 years5%

5 years3%

3 years-7%

1 year-37%

Return on Equity

10 years7%

5 years11%

3 years11%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
7%	6%	0%	3%
-	60%	11%	16%
5%	3%	-7%	-37%
7%	11%	11%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

ALPA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
59	₹129 Cr	29.38	0.47	3.15	₹15 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
—	—	—	—	—	—	—	—	—	—	—	—
₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr	₹21 Cr
₹150 Cr	₹131 Cr	₹114 Cr	₹101 Cr	₹87 Cr	₹79 Cr	₹77 Cr	₹77 Cr	₹74 Cr	₹72 Cr	₹66 Cr	₹67 Cr
₹150 Cr	₹131 Cr	₹114 Cr	₹101 Cr	₹87 Cr	₹79 Cr	₹77 Cr	₹77 Cr	₹74 Cr	₹72 Cr	₹66 Cr	₹67 Cr
₹171 Cr	₹152 Cr	₹135 Cr	₹122 Cr	₹108 Cr	₹100 Cr	₹98 Cr	₹98 Cr	₹95 Cr	₹93 Cr	₹87 Cr	₹88 Cr
₹0	₹0	₹78 L	₹2 Cr	₹91,000	₹19 L	₹41 L	₹61 L	₹47 L	₹0	₹0	₹4 Cr
₹4 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹22 L	-₹93 L	-₹17 L	-₹76 L	-₹66 L	-₹5 L	-₹9 L	₹1 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹63 L	₹60 L	₹51 L	₹51 L
₹4 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹23 L	-₹73 L	₹24 L	-₹15 L	₹44 L	₹55 L	₹41 L	₹6 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹19 Cr	₹12 Cr	₹15 Cr	₹15 Cr	₹25 Cr	₹14 Cr	₹13 Cr	₹13 Cr	₹14 Cr	₹19 Cr	₹9 Cr	₹11 Cr
₹22 Cr	₹10 Cr	₹11 Cr	₹9 Cr	₹6 Cr	₹4 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹5 Cr
₹3 L	₹4 Cr	₹0	₹2 Cr	₹0	₹0	₹1 Cr	₹5 Cr	₹10 Cr	₹24 Cr	₹29 Cr	₹16 Cr
₹6 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹5 Cr	₹1 Cr	₹74 L
₹47 Cr	₹28 Cr	₹30 Cr	₹29 Cr	₹33 Cr	₹21 Cr	₹22 Cr	₹23 Cr	₹30 Cr	₹52 Cr	₹41 Cr	₹32 Cr
₹223 Cr	₹182 Cr	₹167 Cr	₹155 Cr	₹140 Cr	₹120 Cr	₹121 Cr	₹121 Cr	₹125 Cr	₹146 Cr	₹128 Cr	₹127 Cr
₹7 Cr	₹4 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹40 Cr	₹1 Cr
₹3 L	₹5 Cr	₹2 Cr	₹6 Cr	₹19 L	₹41 L	₹2 Cr	₹6 Cr	₹11 Cr	₹24 Cr	₹29 Cr	₹23 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹51 Cr	₹40 Cr	₹33 Cr	₹34 Cr	₹31 Cr	₹40 Cr	₹39 Cr	₹38 Cr	₹36 Cr	₹35 Cr	₹24 Cr	₹102 Cr
₹31 Cr	₹28 Cr	₹26 Cr	₹25 Cr	₹23 Cr	₹34 Cr	₹31 Cr	₹28 Cr	₹25 Cr	₹20 Cr	₹19 Cr	₹29 Cr
₹21 Cr	₹11 Cr	₹7 Cr	₹9 Cr	₹7 Cr	₹6 Cr	₹8 Cr	₹10 Cr	₹11 Cr	₹15 Cr	₹5 Cr	₹73 Cr
₹0	₹0	₹0	₹0	₹2 Cr	₹81 L	₹12 L	₹0	₹0	₹49,000	₹7 L	₹0
₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹10 Cr	₹17 Cr	₹19 Cr	₹13 Cr	₹5 Cr	₹12 Cr	₹10 Cr	₹0
₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹10 Cr	₹17 Cr	₹19 Cr	₹13 Cr	₹5 Cr	₹12 Cr	₹10 Cr	₹0
₹72 L	₹52 L	₹1 Cr	₹22 L	₹23 L	₹24 L	₹13 L	₹0	₹0	₹69 L	₹62 L	₹84 L
₹1 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹11 L	₹20 L	₹30 L	₹0	₹0	₹0	₹0	₹0
₹30 Cr	₹21 Cr	₹18 Cr	₹17 Cr	₹19 Cr	₹25 Cr	₹27 Cr	₹23 Cr	₹20 Cr	₹27 Cr	₹16 Cr	₹74 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹110 Cr	₹91 Cr	₹72 Cr	₹69 Cr	₹41 Cr	₹39 Cr	₹30 Cr	₹18 Cr	₹8 Cr	₹0	₹0	₹0
₹18 Cr	₹14 Cr	₹13 Cr	₹15 Cr	₹17 Cr	₹13 Cr	₹14 Cr	₹14 Cr	₹13 Cr	₹15 Cr	₹8 Cr	₹13 Cr
₹47 Cr	₹41 Cr	₹47 Cr	₹38 Cr	₹35 Cr	₹25 Cr	₹30 Cr	₹26 Cr	₹29 Cr	₹34 Cr	₹24 Cr	₹20 Cr
₹2 Cr	₹2 Cr	₹9 Cr	₹2 Cr	₹11 Cr	₹6 Cr	₹90 L	₹21 Cr	₹37 Cr	₹37 Cr	₹72 Cr	₹10 Cr
₹2 Cr	₹63 L	₹3 Cr	₹5 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹11 Cr	₹2 Cr	₹87 L
₹13 Cr	₹13 Cr	₹6 Cr	₹9 Cr	₹15 Cr	₹12 Cr	₹18 Cr	₹18 Cr	₹16 Cr	₹22 Cr	₹7 Cr	₹8 Cr
₹192 Cr	₹161 Cr	₹149 Cr	₹138 Cr	₹121 Cr	₹95 Cr	₹94 Cr	₹98 Cr	₹105 Cr	₹119 Cr	₹113 Cr	₹53 Cr
₹146 Cr	₹133 Cr	₹119 Cr	₹109 Cr	₹89 Cr	₹75 Cr	₹72 Cr	₹74 Cr	₹75 Cr	₹66 Cr	₹71 Cr	₹20 Cr
₹223 Cr	₹182 Cr	₹167 Cr	₹155 Cr	₹140 Cr	₹120 Cr	₹121 Cr	₹121 Cr	₹125 Cr	₹146 Cr	₹128 Cr	₹127 Cr
₹81	₹72	₹64	₹58	₹51	₹48	₹47	₹46	₹45	₹44	₹41	₹42
₹81	₹72	₹64	₹58	₹51	₹48	₹47	₹46	₹45	₹44	₹41	₹42

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
₹26 Cr	₹21 Cr	₹16 Cr	₹20 Cr	₹11 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹10 Cr	-₹3 Cr	-₹5 Cr
-₹16 Cr	-₹9 Cr	-₹2 Cr	-₹8 Cr	₹73 L	₹6 Cr	₹79 L	₹82 L	₹61 L	-₹21 L	₹6 Cr	₹12 Cr
₹12 Cr	-₹4 Cr	-₹80 L	₹1 Cr	-₹10 Cr	₹10 Cr	-₹2 Cr	-₹16 Cr	₹14 Cr	-₹28 Cr	-₹7 Cr	₹1 Cr
₹22 Cr	₹7 Cr	₹12 Cr	₹13 Cr	₹1 Cr	₹19 Cr	₹1 Cr	-₹11 Cr	₹20 Cr	-₹19 Cr	-₹3 Cr	₹8 Cr
₹18 Cr	₹4 Cr	₹9 Cr	₹10 Cr	-₹2 Cr	₹18 Cr	-₹1 Cr	-₹13 Cr	₹17 Cr	-₹22 Cr	-₹2 Cr	₹8 Cr
-₹12 Cr	-₹13 Cr	₹2 Cr	-₹16 Cr	₹6 Cr	-₹11 Cr	-₹15 Cr	-₹11 Cr	-₹2 Cr	-₹8 Cr	₹37 Cr	-₹2 Cr
-₹5 Cr	₹3 Cr	-₹4 Cr	₹5 Cr	₹18 L	-₹1 Cr	-₹5 Cr	₹9 Cr	-₹15 Cr	-₹6 Cr	₹7 Cr	₹4 Cr
₹51 L	-₹7 Cr	₹7 Cr	-₹23 L	₹4 Cr	₹5 Cr	-₹20 Cr	-₹15 Cr	₹5 L	-₹35 Cr	₹42 Cr	₹10 Cr
₹3 Cr	₹10 Cr	₹2 Cr	₹2 Cr	₹6 Cr	₹90 L	₹21 Cr	₹37 Cr	₹37 Cr	₹53 Cr	₹10 Cr	₹53 L
₹4 Cr	₹3 Cr	₹9 Cr	₹2 Cr	₹11 Cr	₹6 Cr	₹90 L	₹21 Cr	₹37 Cr	₹17 Cr	₹53 Cr	₹10 Cr

Fundamental Ratios

Consolidated

Standalone

Alpa Laboratories Share Price

59.07+0.00 (-2.19%)

-36.61% past 1 Year

Shareholding summary

Promoters

57.19%

FII

0.35%

DII

0.07%

Others

42.39%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
57.19%	57.19%	57.29%	57.29%	57.29%	57.29%
0.35%	0.38%	0.36%	0.35%	0.36%	0.40%
0.07%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
42.39%	42.43%	42.35%	42.36%	42.35%	42.31%

Bulk & block deals

Name

Aakraya Research Llp

Qe Securities Llp

Nk Securities Research Private Limited

Mudupulavemula Surendranadha Reddy

Hrti Private Limited

Microcurves Trading Private Limited

Aakraya Research Llp

Qe Securities Llp

Nk Securities Research Private Limited

Mudupulavemula Surendranadha Reddy

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Sep 2024	Purchase	3.46 Cr	₹140.07	2.47 L	Bulk	1.172562	NSE
30 Sep 2024	Purchase	2.85 Cr	₹139.76	2.04 L	Bulk	0.968627	NSE
30 Sep 2024	Purchase	2.55 Cr	₹138.69	1.84 L	Bulk	0.873592	NSE
30 Sep 2024	Purchase	2.36 Cr	₹139.21	1.69 L	Bulk	0.80453	NSE
30 Sep 2024	Purchase	2.17 Cr	₹139.42	1.56 L	Bulk	0.740217	NSE
30 Sep 2024	Purchase	1.70 Cr	₹139.54	1.22 L	Bulk	0.580359	NSE
30 Sep 2024	Sell	3.46 Cr	₹140.23	2.47 L	Bulk	1.172562	NSE
30 Sep 2024	Sell	2.81 Cr	₹139.75	2.01 L	Bulk	0.95416	NSE
30 Sep 2024	Sell	2.55 Cr	₹138.79	1.84 L	Bulk	0.873592	NSE
30 Sep 2024	Sell	2.36 Cr	₹139.35	1.69 L	Bulk	0.80453	NSE

Insider trading & SAST

Client name

Vinit Shah

Bakulesh Chandulal Shah Huf

Paresh Chawla

Pravin Shah

Shitul Shah

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
08 Apr 2026	Promoter	Acquisition	0.1	0.1	—	21.94 K	07 Mar 2026	Off Market / Inter se transfer	21,940	SAST	29(2)	—
08 Apr 2026	Other	Acquisition	0.1	—	—	21.94 K	07 Mar 2026	-	—	SAST	10(6)	—
07 Mar 2026	Promoters Immediate Relative	Acquisition	0.104275	0.1	—	21.94 K	07 Mar 2026	Gift	21,940	Insider Trading	—	Equity Shares
07 Mar 2026	Promoter	Disposal	0.104275	0	—	21.94 K	07 Mar 2026	Gift	0	Insider Trading	—	Equity Shares
05 Jul 2025	Other	Acquisition	16.74	—	—	35.22 L	13 Jun 2025 - 17 Jun 2025	-	—	SAST	10(6)	—
05 Jul 2025	Promoter	Disposal	0.52	5.23	—	1.09 L	16 Jun 2025	Off Market	11,01,580	SAST	29(2)	—
05 Jul 2025	Other	Acquisition	0.52	—	—	1.09 L	16 Jun 2025	-	—	SAST	10(6)	—
05 Jul 2025	Promoter	Acquisition	0.52	4.92	—	1.09 L	16 Jun 2025	Off Market	10,34,200	SAST	29(2)	—
05 Jul 2025	Promoter	Acquisition	5.23	10.15	—	11.01 L	25 Jun 2025	Off Market	21,34,780	SAST	29(2)	—
05 Jul 2025	Other	Acquisition	5.23	—	—	11.01 L	25 Jun 2025	-	—	SAST	10(6)	—

Alpa Laboratories Share Price

59.07+0.00 (-2.19%)

-36.61% past 1 Year

Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber about 15 kilometers from the city of Indore in Central India. The company has been manufacturing

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

33/2 Pigdamber A B Road Rau Indore Dist Madhya Pradesh PIN: 453446 Tel No: 0731-4294567 Fax No: 0730-4294444 Email: [email protected] Internet: www.alpalabs.in

Registrars

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]

Management

Mahendra Singh Chawla, Chairman

Paresh Chawla, Managing Director

Pravin Shah, Whole Time Director

Shitul Shah, Whole Time Director

Vitthal Kothana, Whole Time Director

Sunil Valecha, Non Executive Independent Director

Sanket Baheti, Non Executive Independent Director

Pratibha Lunawat, Non Executive Independent Director

Pratik Shah, Non Executive Independent Director

Details

BSE 532878

NSE ALPA

ISIN INE385I01010

Alpa Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Alpa Laboratories Share Price

Alpa Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Alpa Laboratories Share Price

Alpa Laboratories Share Price

Oscillators

Moving averages

Alpa Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Alpa Laboratories Share Price

Corporate Actions

Company details

Alpa Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Alpa Laboratories Share Price

News

Alpa Laboratories board approves overseas subsidiary Alpa Biopharm in Nigeria

Alpa Lab reports Profit after tax of 7.63 Crores, in the September 2024 quarter

Alpa Lab - Quaterly Results

Alpa Lab reports Profit after tax of 5.12 Crores, in the June 2024 quarter

Alpa Lab reports Profit after tax of 3.55 Crores, in the March 2024 quarter

Alpa Lab - Quaterly Results

Alpa Lab reports Profit after tax of 4.53 Crores, in the December 2023 quarter

Alpa Lab - Quaterly Results

Alpa Laboratories informs about closure of trading window

Alpa Lab reports Profit after tax of 5.74 Crores, in the September 2023 quarter

Alpa Lab - Quaterly Results

Alpa Lab reports Profit after tax of 3.03 Crores, in the June 2023 quarter

Alpa Lab reports Profit after tax of 4.62 Crores, in the March 2023 quarter

Alpa Lab reports Profit after tax of 5.14 Crores, in the December 2022 quarter

Alpa Laboratories informs about RPT disclosure

Alpa Laboratories Ltd Share Price Today

Alpa Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator